Arcadia Biosciences, Inc.
RKDA
Revenue
1.31M
▲51.00k▲4.06%
3 Months ChangeAssets
17.37M
▲1.32M▲8.25%
3 Months ChangeLiabilities
5.80M
▲240.00k▲4.31%
3 Months ChangeFree Cash Flow
-3.22M
▲243.00k▲7.01%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
Date | Revenue | Cost Of Revenue |
---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
Date | Net Profit/Loss |
---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
Date | Assets | Liabilities |
---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
Date | EPS | EPS (Diluted) |
---|---|---|
Outstanding Shares
Loading...
Date | Outstanding Shares |
---|---|
Recent 8-K/10-Q Filings
2024-08-13
Form 10-Q
ID: 0000950170-24-096439
2024-08-13
Form 8-K
ID: 0000950170-24-096215
2024-08-07
Form 8-K
ID: 0000950170-24-092432
2024-07-08
Form 8-K
ID: 0000950170-24-082092
2024-07-01
Form 8-K
ID: 0000950170-24-079602
2024-05-20
Form 8-K
ID: 0000950170-24-062449
2024-05-17
Form 8-K
ID: 0000950170-24-061526
2024-05-13
Form 10-Q
ID: 0000950170-24-058563
2024-05-09
Form 8-K
ID: 0000950170-24-056928
2024-03-28
Form 8-K
ID: 0000950170-24-038153